关于pH保持时间与侵蚀性食道炎愈合率之间的关系的数学模型
Colin W Howden1, Carmelo Scarpignato2, Eckhard Leifke3
1University of Tennessee College of Medicine, Memphis, Tennessee, USA.
CPT: pharmacometrics & systems pharmacology
|September 19, 2024
概括
与竞争性酸阻断剂 (P-CABs) 提供优越的酸抑制,导致与质子抑制剂 (PPI) 和组胺H2受体对抗剂 (H2RAs) 相比,侵蚀性食道炎的愈合率更高. 这项研究模拟了它们的有效性.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 生物统计学 生物统计学
背景情况:
- 侵蚀性食道炎的愈合与胃酸抑制有关.
- 目前的治疗方法包括组胺H2受体对抗剂 (H2RA) 和质子抑制剂 (PPI).
- 竞争性酸阻断剂 (P-CABs) 是一种新兴的酸抑制剂类.
研究的目的:
- 模拟胃内pH保持时间比率 (HTRs) 与侵蚀性食道炎的愈合率之间的关系.
- 为了比较H2RA,PPI和P-CAB在达到治疗性pH值和治愈结果方面的疗效.
主要方法:
- 对报告平均pH>4HTR和H2RA,PPI和P-CAB的愈合率的研究进行文献搜索.
- 开发一种非线性混合效应模型,分析pH>4 HTR与愈合率之间的关联.
- 按药物类别汇总数据,包括82项研究 (4297名参与者) 的pH数据和103项研究 (43,417名患者) 的治愈率.
主要成果:
- 在P-CAB测试中,胃内pH值>4.4的持续时间最长.
- 在4周和8周,P-CAB与最高的愈合率有关.
- 在8周内实现≥90%治愈的预测概率为P-CABs的74.1%,PPI的17.3%,H2RAs的0%.
结论:
- 与PPI和H2RA相比,P-CABs提供了优越的胃内酸抑制.
- 通过P-CABs增强的酸性控制转化为侵蚀性食道炎的明显更高的愈合率.
- 数学建模证实P-CABs是侵蚀性食道炎的高效治疗选择.
相关概念视频
Henderson-Hasselbalch Equation
68.6K
The ionization-constant expression for a solution of a weak acid can be written as:
68.6K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
544
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
544
Calculating pH Changes in a Buffer Solution
53.0K
A buffer can prevent a sudden drop or increase in the pH of a solution after the addition of a strong acid or base up to its buffering capacity; however, such addition of a strong acid or base does result in the slight pH change of the solution. The small pH change can be calculated by determining the resulting change in the concentration of buffer components, i.e., a weak acid and its conjugate base or vice versa. The concentrations obtained using these stoichiometric calculations can be used...
53.0K
Peptic Ulcer Disease II: Pathophysiology
320
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
320
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
357
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
357
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74


